Battens disease is one of the ceroid lipofuscinoses, characterized by juvenile onset of visual loss, seizures, and mental detrioration. The disease is characterized by autofluorescent pigment deposition in lysosomal structures. The gene for Battens disease (CLN3) was cloned by positional cloning - it appears to be a transmembrane protein located in the golgi. We have created a mouse with a deletion mutation in Cln3, the mouse ortholog to the human gene. These mice develop pigment deposition as is seen in affected humans. Studies are ongoing to determine if any of the other phenotypic abnormalities seen in Battens disease patients also develop in the mice. - Brain Disorders, Batten's Disease, Neurodegenerative

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Intramural Research (Z01)
Project #
1Z01HG000141-01
Application #
6227986
Study Section
Special Emphasis Panel (GDRB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Human Genome Research Institute
Department
Type
DUNS #
City
State
Country
United States
Zip Code